Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Applied Endocrinology in Egypt. 1988; 7 (2): 294-307
in English | IMEMR | ID: emr-10078

ABSTRACT

The aim of this work was to study the effects of aging on the cellular-mediated immune response and to search for any alterations in the total lymphocyte count and the absolute number of T-lymphocytes accompanying aging of man. This study was carried out on: thirty four Egyptian farmers above 60 years old [mean age= 66.4 years] and they were 22 females + 12 males and they were apparently healthy and on 17 healthy Egyptian farmers [mean age = 37.6 years] and they were 9 females + 8 males as control. All studied individuals were subjected to full history taking, clinical examination and fresh samples of peripheral blood were taken to count the total lymphocytes, and the lymphocytes had been isolated using the ficoll-hypaque. The absolute T-lymphocytes were estimated using the E-rosette formation between sheep RBC's and the lymphocyte suspension. T-cell percent to total lymphocytes were estimated. Results showed that: - There were no decrease in the lymphocyte count with aging; in the older group it was =2113/mm[3] while in the control group, it was 2106/mm[3]. The percentage of T-lymphocytes showed no appreciable change with aging; in the geriatric group it was =69.2% while in the control group = 69.5% i.e. As light decrease with aging had happened. The absolute T-lymph count showed no change with aging: In the old group it was =1465/mm[3], while in the control group = 1459 /mm[3] i.e. in both groups it was [nearly] equal. From these results, it was concluded that; aging is not accompanied with alterations in the total lymphocytic count or in the absolute T-cell number/mm[3]. It was referred that aging is associated with changes in cell-mediated immune response, these changes are mainly functional and due to alterations in the T-cell subset-proportions in the body of man


Subject(s)
Humans , Male , Immunity, Cellular , T-Lymphocytes , Antibody Formation , Leukocyte Count
2.
Journal of the Egyptian Society of Endocrinology, Metabolism and Diabetes [The]. 1987; 19 (2): 23-43
in English | IMEMR | ID: emr-136148

ABSTRACT

Hyperprolactinemia occurs frequently in patients with chronic renal failure and it persists despite dialysis treatment. Hence the study of the actual change in PRL level after a hemodialysis set is essentially reported. Thirty non diabetic male patients with chronic renal failure were selected from Dialysis Units of Port-Said and Ismailia General Hospitals where they underwent chronic hemodialysis [CHD] for all cases the following had been done: full medical history, full clinical examination. determination of fasting serum glucose to exclude diabetics as well as serum urea, creatinine, total proteins and PRL before and after a hemodialysis set. The results obtained showed: 1. There is a significant hyperprolactinemia among patients on CHD 2. PRL does not significantly change after the set [insignificantly increased]. 3. Some patients have sexual dysfunction and gynecomastia. Finally from our results we conclude that patients undergoing hemodialysis are prone to have clinically significant hyperprolactinemia that may impair their sexual function. Since this complication diminishes the quality of life and limits psychological rehabiltitation, we recommend treatment with bromocriptine [dopamine agonist] to chronic renal failure patients on hemodialysis with sexual dysfunction and exhibit high prolactin


Subject(s)
Humans , Male , Renal Dialysis/adverse effects , Prolactin/blood , Growth Hormone/blood , Insulin/blood , Hyperprolactinemia/blood
3.
Journal of the Egyptian Society of Endocrinology, Metabolism and Diabetes [The]. 1986; 18 (1): 22-30
in English | IMEMR | ID: emr-118449
SELECTION OF CITATIONS
SEARCH DETAIL